The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-(3,5-dichloro-4-ethoxyphenyl)oxazol-2-yl)benzoic acid ID: ALA4517145
Chembl Id: CHEMBL4517145
PubChem CID: 155540995
Max Phase: Preclinical
Molecular Formula: C18H13Cl2NO4
Molecular Weight: 378.21
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1c(Cl)cc(-c2cnc(-c3ccc(C(=O)O)cc3)o2)cc1Cl
Standard InChI: InChI=1S/C18H13Cl2NO4/c1-2-24-16-13(19)7-12(8-14(16)20)15-9-21-17(25-15)10-3-5-11(6-4-10)18(22)23/h3-9H,2H2,1H3,(H,22,23)
Standard InChI Key: PNCYUHNQVYHNOF-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.21Molecular Weight (Monoisotopic): 377.0222AlogP: 5.41#Rotatable Bonds: 5Polar Surface Area: 72.56Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.76CX Basic pKa: 0.55CX LogP: 4.57CX LogD: 1.29Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.64Np Likeness Score: -0.88
References 1. Goncalves MB, Clarke E, Jarvis CI, Barret Kalindjian S, Pitcher T, Grist J, Hobbs C, Carlstedt T, Jack J, Brown JT, Mills M, Mumford P, Borthwick AD, Corcoran JPT.. (2019) Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury., 29 (8): [PMID:30792038 ] [10.1016/j.bmcl.2019.02.011 ]